|
SLC38A7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.805300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.424200E-04 |
| Normal-vs-Stage2 |
4.371800E-01 |
| Normal-vs-Stage3 |
4.078400E-03 |
| Normal-vs-Stage4 |
3.229100E-04 |
| Stage1-vs-Stage2 |
3.515800E-02 |
| Stage1-vs-Stage3 |
8.210200E-01 |
| Stage1-vs-Stage4 |
2.619200E-01 |
| Stage2-vs-Stage3 |
6.720200E-02 |
| Stage2-vs-Stage4 |
1.477720E-02 |
| Stage3-vs-Stage4 |
3.787800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.159600E-04 |
| Normal-vs-AfricanAmerican |
4.856400E-03 |
| Normal-vs-Asian |
1.297670E-02 |
| Caucasian-vs-AfricanAmerican |
5.983400E-01 |
| Caucasian-vs-Asian |
9.311800E-01 |
| AfricanAmerican-vs-Asian |
7.650400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.847800E-04 |
| Normal-vs-Female |
1.702990E-03 |
| Male-vs-Female |
4.607200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.916640E-03 |
| Normal-vs-Age(41-60Yrs) |
4.247500E-04 |
| Normal-vs-Age(61-80Yrs) |
6.040400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.255700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.846000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.556400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.637200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.059610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.766000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.832800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.564000E-01 |
| Classical-VS-Follicular |
2.380000E-01 |
| Classical-VS-Other |
2.219000E-01 |
| Classical-VS-Normal |
6.408500E-04 |
| Tall-VS-Follicular |
1.206160E-01 |
| Tall-VS-Other |
4.928200E-01 |
| Tall-VS-Normal |
5.681800E-03 |
| Follicular-VS-Other |
2.253000E-01 |
| Follicular-VS-Normal |
1.492370E-01 |
| Other-VS-Normal |
2.801900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.430460E-02 |
| Normal-vs-N1 |
5.033600E-04 |
| N0-vs-N1 |
7.705600E-02 |
|
|
